Prime Plus

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-03-01
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:03

Label at a glance#

ProductPrime Plus

Active ingredientChaste Tree, Garlic, Ambergris, Angelica Sinensis Root, American Ginseng, Arnica Montana, Arsenic Trioxide, Avena Sativa Flowering Top, Baptisia Tinctoria Root, Barium Carbonate, Bryonia Alba Root, Lytta Vesicatoria, Lachesis Muta Venom, Lycopodium Clavatum Spore, Strychnos Nux-vomica Seed, Phosphoric Acid, Pulsatilla Vulgaris, Ruta Graveolens Flowering Top, Saw Palmetto, Selenium, Zinc, Ginkgo

Label structure10 sections

Indications and uses

Prime+ Formulated for symptoms associated with aging such as impaired memory, loss of vitality, general weakness and dry, wrinkled skin.

Dosage and administration

Directions: Adults, take 6 pellets orally one to four times daily or as directed by a healthcare professional. Sensitive persons begin with 1 pellet and gradually increase to full dose.

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS AND USAGE SECTION

INDICATIONS & USAGE SECTION

Prime+ Formulated for symptoms associated with aging such as impaired memory, loss of vitality, general weakness and dry, wrinkled skin.

DOSAGE AND ADMINISTRATION SECTION

DOSAGE & ADMINISTRATION SECTION

Directions: Adults, take 6 pellets orally one to four times daily or as directed by a healthcare professional. Sensitive persons begin with 1 pellet and gradually increase to full dose.

OTC ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Agnus 10x, Allium sativum 10x, Ambra10x, Angelica sinensis radix 10x, Aralia quinquefolia 10x, Arnica 10x, Arsenicum alb. 10x, Avena 10x, Baptisia 10x, Baryta carb. 10x, Bryonia 10x, Cantharis 10x, Lachesis 10x, Lycopodium 10x, Nux vom.10x, Phosphoricum ac. 10x, Pulsatilla 10x, Ruta 10x, Sabal 10x, Selenium 10x, Zinc. met. 10x, Ginkgo 3x, Ruta 3x.

OTC PURPOSE SECTION

OTC - PURPOSE SECTION

Formulated for symptoms associated with aging such as impaired memory, loss of vitality, general weakness and dry, wrinkled skin.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
86fffa7b-d382-4771-a253-25cccb64b590	Product name	3	20251124
63f39a63-5cd1-4016-bd86-2bbb0f6c3139	Product name	3	20240506
e5a77e9c-c528-733a-173d-914a234c024b	Product name	5	20240506
0306390c-dd77-4363-afe0-63c58088b2a1	Product name	1	20220120
503ea967-4b9c-48cf-9e87-c7975295849d	Product name	2	20220120

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-1105-0	2020-01-31	C162847	48780-1	9d75b9d0-000d-f424-e053-dadaa90a57ce	Prime +
55714-1105-1	2020-01-31	C162847	48780-1	9d75b9d0-000d-f424-e053-dadaa90a57ce	Prime +
55714-1105-2	2020-01-31	C162847	48780-1	9d75b9d0-000d-f424-e053-dadaa90a57ce	Prime +

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
55714-1105-0	Prime Plus	7.08 g in 1 BOTTLE, GLASS	PELLET	7.08	1
55714-1105-1	Prime Plus	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35	1
55714-1105-2	Prime Plus	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-1105	PRIME PLUS (AGNUS, ALLIUM SATIVUM, AMBRA, ANGELICA SINENSIS RADIX, ARALIA QUINQUEFOLIA, ARNICA, ARSENICUM ALB., AVENA, BAPTISIA, BARYTA CARB., BRYONIA, CANTHARIS, LACHESIS, LYCOPODIUM, NUX VOM., PHOSPHORICUM AC., PULSATILLA, RUTA, SABAL, SELENIUM, ZINC. MET., GINKGO) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 3 package rows	20131018_f509acb7-073e-3bb3-adb0-3440d300b1a9.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Ambergris	ACTIVE INGREDIENT	XTC0D02P6C	1
American Ginseng	ACTIVE INGREDIENT	8W75VCV53Q	1
Angelica Sinensis Root	ACTIVE INGREDIENT	B66F4574UG	1
Arnica Montana	ACTIVE INGREDIENT	O80TY208ZW	1
Arsenic Trioxide	ACTIVE INGREDIENT	S7V92P67HO	1
Avena Sativa Flowering Top	ACTIVE INGREDIENT	MA9CQJ3F7F	1
Baptisia Tinctoria Root	ACTIVE INGREDIENT	5EF0HWI5WU	1
Barium Carbonate	ACTIVE INGREDIENT	6P669D8HQ8	1
Bryonia Alba Root	ACTIVE INGREDIENT	T7J046YI2B	1
Chaste Tree	ACTIVE INGREDIENT	433OSF3U8A	1
Garlic	ACTIVE INGREDIENT	V1V998DC17	1
Ginkgo	ACTIVE INGREDIENT	19FUJ2C58T	1
Lachesis Muta Venom	ACTIVE INGREDIENT	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE INGREDIENT	C88X29Y479	1
Lytta Vesicatoria	ACTIVE INGREDIENT	3Q034RO3BT	1
Phosphoric Acid	ACTIVE INGREDIENT	E4GA8884NN	1
Pulsatilla Vulgaris	ACTIVE INGREDIENT	I76KB35JEV	1
Ruta Graveolens Flowering Top	ACTIVE INGREDIENT	N94C2U587S	1
Saw Palmetto	ACTIVE INGREDIENT	J7WWH9M8QS	1
Selenium	ACTIVE INGREDIENT	H6241UJ22B	1
Strychnos Nux-vomica Seed	ACTIVE INGREDIENT	269XH13919	1
Zinc	ACTIVE INGREDIENT	J41CSQ7QDS	1
Ambergris	ACTIVE MOIETY	XTC0D02P6C	1
American Ginseng	ACTIVE MOIETY	8W75VCV53Q	1
Angelica Sinensis Root	ACTIVE MOIETY	B66F4574UG	1
Arnica Montana	ACTIVE MOIETY	O80TY208ZW	1
Arsenic Cation (3+)	ACTIVE MOIETY	C96613F5AV	1
Avena Sativa Flowering Top	ACTIVE MOIETY	MA9CQJ3F7F	1
Baptisia Tinctoria Root	ACTIVE MOIETY	5EF0HWI5WU	1
Barium Cation	ACTIVE MOIETY	V645272HLN	1
Bryonia Alba Root	ACTIVE MOIETY	T7J046YI2B	1
Chaste Tree	ACTIVE MOIETY	433OSF3U8A	1
Garlic	ACTIVE MOIETY	V1V998DC17	1
Ginkgo	ACTIVE MOIETY	19FUJ2C58T	1
Lachesis Muta Venom	ACTIVE MOIETY	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE MOIETY	C88X29Y479	1
Lytta Vesicatoria	ACTIVE MOIETY	3Q034RO3BT	1
Phosphoric Acid	ACTIVE MOIETY	E4GA8884NN	1
Pulsatilla Vulgaris	ACTIVE MOIETY	I76KB35JEV	1
Ruta Graveolens Flowering Top	ACTIVE MOIETY	N94C2U587S	1
Saw Palmetto	ACTIVE MOIETY	J7WWH9M8QS	1
Selenium	ACTIVE MOIETY	H6241UJ22B	1
Strychnos Nux-vomica Seed	ACTIVE MOIETY	269XH13919	1
Zinc	ACTIVE MOIETY	J41CSQ7QDS	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

Prime Plus
Agnus, Allium sativum, Ambra, Angelica sinensis radix, Aralia quinquefolia, Arnica, Arsenicum alb., Avena, Baptisia, Baryta carb., Bryonia, Cantharis, Lachesis, Lycopodium, Nux vom., Phosphoricum ac., Pulsatilla, Ruta, Sabal, Selenium, Zinc. met., Ginkgo
Chaste Tree
Garlic
Ambergris
Angelica Sinensis Root
American Ginseng
Arnica Montana
Arsenic Trioxide
Arsenic Cation (3+)
Avena Sativa Flowering Top
Baptisia Tinctoria Root
Barium Carbonate
Barium Cation
Bryonia Alba Root
Lytta Vesicatoria
Lachesis Muta Venom
Lycopodium Clavatum Spore
Strychnos Nux-vomica Seed
Phosphoric Acid
Pulsatilla Vulgaris
Ruta Graveolens Flowering Top
Saw Palmetto
Selenium
Zinc
Ginkgo
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-1105	55714-1105-1, 55714-1105-2, 55714-1105-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Chaste Tree	433OSF3U8A	ACTIB
Garlic	V1V998DC17	ACTIB
Ambergris	XTC0D02P6C	ACTIB
Angelica Sinensis Root	B66F4574UG	ACTIB
American Ginseng	8W75VCV53Q	ACTIB
Arnica Montana	O80TY208ZW	ACTIB
Arsenic Trioxide	S7V92P67HO	ACTIB
Avena Sativa Flowering Top	MA9CQJ3F7F	ACTIB
Baptisia Tinctoria Root	5EF0HWI5WU	ACTIB
Barium Carbonate	6P669D8HQ8	ACTIB
Bryonia Alba Root	T7J046YI2B	ACTIB
Lytta Vesicatoria	3Q034RO3BT	ACTIB
Lachesis Muta Venom	VSW71SS07I	ACTIB
Lycopodium Clavatum Spore	C88X29Y479	ACTIB
Strychnos Nux-vomica Seed	269XH13919	ACTIB
Phosphoric Acid	E4GA8884NN	ACTIB
Pulsatilla Vulgaris	I76KB35JEV	ACTIB
Ruta Graveolens Flowering Top	N94C2U587S	ACTIB
Saw Palmetto	J7WWH9M8QS	ACTIB
Selenium	H6241UJ22B	ACTIB
Zinc	J41CSQ7QDS	ACTIB
Ginkgo	19FUJ2C58T	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
a36044af-cc69-5ca4-22d0-2f284b542ab0			f509acb7-073e-3bb3-adb0-3440d300b1a9	2011-03-01	Warnings	Exact identifier spl id: a36044af-cc69-5ca4-22d0-2f284b542ab0 spl set id: f509acb7-073e-3bb3-adb0-3440d300b1a9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.